pISSN 1226-6051
eISSN 2508-786X

Table. 3.

Table. 3.

Healthcare Utilization of Prescriptions of Osteoporosis Treatments, 2018

(unit: person) Anti-resorptives Bone-forming


Bisphosphonates SERMs Denosumab Calcitonin Total Anti-resorptives Teriparatide
Total, n(%) 140,897(78.2%) 24,708(13.7%) 1,280(0.7%) 12,277(6.8%) 179,162(99.4%) 1,002(0.6%)
Annual No. of medical utilization per person Mean±SD
No. of hospitalizations 0.1±0.6 0.1±0.4 0.1±0.4 0.4±0.7 0.1±0.5 0.8±1.3
No. of outpatient visits 3.7±3.3 4.6±3.6 2.6±1.9 9.9±14.1 3.9±4.0 4.3±4.3
Type of hospitals, n(%)
Tertiary hospitals 6,178(4.4%) 2,376(9.6%) 289(22.6%) 11(0.1%) 8,854(4.9%) 134(13.4%)
General hospitals 16,691(11.9%) 4,353(17.6%) 338(26.4%) 202(1.7%) 21,584(12.1%) 271(27.1%)
Hospitals 19,468(13.8%) 2,772(11.2%) 183(14.3%) 1,062(8.7%) 23,485(13.1%) 506(50.5%)
Clinics 96,453(68.5%) 14,979(60.6%) 468(36.6%) 11,002(89.6%) 122,902(68.6%) 91(9.1%)
Health center 2,107(1.5%) 228(0.9%) 2(0.2%) - (0.0%) 2,337(1.3%) - (0.0%)
Department, n(%)
Orthopedic surgery 57221(40.6%) 8313(33.6%) 414(32.3%) 8742(71.2%) 74,690(41.7%) 463(46.2%)
Internal medicine 50,710(36.0%) 11,061(44.8%) 566(44.2%) 1,299(10.6%) 63,636(35.5%) 105(10.5%)
Obstetrics and gynecology 4,432(3.2%) 1,139(4.6%) 65(5.1%) 138(1.1%) 5,774(3.2%) 39(3.9%)
Neurosurgery 8,779(6.2%) 1,336(5.4%) 106(8.3%) 355(2.9%) 10,576(5.9%) 360(35.9%)
Family medicine 5,165(3.7%) 985(4.0%) 57(4.5%) 387(3.2%) 6,594(3.7%) 24(2.4%)
Others 14,590(10.4%) 1,874(7.6%) 72(5.6%) 1,356(11.1%) 17,892(10.0%) 11(1.1%)

* Comparisons (bone-forming agents vs. anti-resorptives) that are statistically significant at p<0.05 are noted by .

* Patients and prescriptions can be counted in more than one category

Abbreviation: SD, standard deviation; SERMs, Selective Estrogen Receptor Modulators

Korean J Clin Pharm 2021;31:27-34 https://doi.org/10.24304/kjcp.2021.31.1.27
© 2021 Korean J Clin Pharm